Barely Significant
← all excerpts

Cyclic Fasting-Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia.

Cancer Res · 2024 · PMC10982641 · PMID 38241703

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
When used alone, FMD or bortezomib + rituximab reduced spleen weight, while the FMD + bortezomib + rituximab combination showed a trend toward an additional reduction in splenomegaly ( Fig. 6A ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.